Voltar
Revisão Revisado por pares
BIBTEX RIS

Actinic keratosis

2007; Wiley; Volume: 46; Issue: 9 Linguagem: Inglês

10.1111/j.1365-4632.2007.03166.x

ISSN

1365-4632

Autores

Riccardo Rossi, Moira Mori, Torello Lotti,

Tópico(s)

Cutaneous Melanoma Detection and Management

Resumo

International Journal of DermatologyVolume 46, Issue 9 p. 895-904 Actinic keratosis Riccardo Rossi MD, Riccardo Rossi MD From the University Unit of Dermatology and Physiotherapy, School of Medicine, University of Florence, Florence, ItalySearch for more papers by this authorMoira Mori MD, Moira Mori MD From the University Unit of Dermatology and Physiotherapy, School of Medicine, University of Florence, Florence, ItalySearch for more papers by this authorTorello Lotti MD, Torello Lotti MD From the University Unit of Dermatology and Physiotherapy, School of Medicine, University of Florence, Florence, ItalySearch for more papers by this author Riccardo Rossi MD, Riccardo Rossi MD From the University Unit of Dermatology and Physiotherapy, School of Medicine, University of Florence, Florence, ItalySearch for more papers by this authorMoira Mori MD, Moira Mori MD From the University Unit of Dermatology and Physiotherapy, School of Medicine, University of Florence, Florence, ItalySearch for more papers by this authorTorello Lotti MD, Torello Lotti MD From the University Unit of Dermatology and Physiotherapy, School of Medicine, University of Florence, Florence, ItalySearch for more papers by this author First published: 03 September 2007 https://doi.org/10.1111/j.1365-4632.2007.03166.xCitations: 71 Riccardo Rossi, MD University Unit of Dermatology and Physiotherapy School of Medicine University of Florence Via Lorento il Magnifico, 104, 50129 Florence Italy E-mail: [email protected] Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Feldman SR, Fleischer AB Jr, McConnell C. Most common dermatologic problems identified by internists, 1990–1994. Arch Intern Med 1998; 158: 649–655. 2 Marks R, Jolley D, Dorevitsh AP, et al. The incidence of non-melanocytic skin cancer in an Australian population: results of a five year prospective study. Med J Aust 1989; 150: 475–478. 3 Frost CA, Green AC. Epidemiology of solar keratoses. Br J Dermatol 1994; 151: 455–464. 4 Yantos VA, Conrad N, Azbawski E, et al. Incipient intraepidermal cutaneous squamous cell carcinoma: a proposal for reclassifying and grading solar (actinic) keratosis. Semin Cutan Med Surg 1999; 1: 3–14. 5 Salasche SJ. Epidemiology of actinic keratoses and squamous cell carcinoma. J Am Acad Dermatol 2000; 42: 8–10. 6 Cockerell CJ. Histopathology of incipient intraepidermal squamous cell carcinoma ("actinic keratosis"). J Am Acad Dermatol 2000; 115: 649–655. 7 Ackerman AB. Respect at last for solar keratosis. Dermatopathol: Pract Concept 1997; 3: 101–103. 8 Ortonne JP. From actinic keratosis to squamous cell carcinoma. Br J Dermatol 2002; 146: 20–23. 9 Schmook T, Stockfleth E. Current treatment patterns in non melanoma skin cancer across Europe. J Dermatol Treat 2003; 14: 3–10. 10 Drake LA, Ceilley RI, Cornelison RL, et al. Guidelines of care for actinic keratoses. J Am Acad Dermatol 1995; 32: 95–98. 11 Dodson JM, DeSpain J, Hewett JE, et al. Malignant potential of actinic keratoses and the controversy over treatment. A patient-oriented perspective. Arch Dermatol 1991; 127: 1029–1031. 12 Ilyas EN, Grana G, Green JJ. Inflammatory actinic keratoses secondary to systemic chemotherapy. Cutis 2005; 75: 167–168. 13 Dragieva G, Prinz BM, Hafner J, et al. A randomized controlled clinical trial of topical photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratoses in transplant recipients. Br J Dermatol 2004; 151: 196–200. 14 Berking C, Takemoto R, Binder RL, et al. Photocarcinogenesis in human adult skin grafts. Carcinogenesis 2002; 23: 181–187. 15 Speight EL, Dahl MG, Farr PM. Actinic keratosis induced by use of sunbed. Br Med J 1994; 308: 415. 16 Diffey B. Climate change, ozone depletion and the impact on ultraviolet exposure of human skin. Phys Med Biol 2004; 49: R1–R11. 17 Yu RCH, Pryce DW, MacFarlane AQ, et al. A histopathological study of 643 cutaneous horns. Br J Dermatol 1991; 24: 449–452. 18 Butani A, Arbesfeld DM, Schwartz RA. Premalignant and early squamous cell carcinoma. Clin Plast Surg 2005; 32: 223–235. 19 Olsen EA, Abernethy ML, Kulp-Shorten C, et al. A double-blind, vehicle-controlled study evaluating masoprocol cream in the treatment of actinic keratoses on the head and neck. J Am Acad Dermatol 1991; 5: 738–743. 20 Yantos V. Continuous spectrum between actinic keratoses and SCC, analogous to CIN (cervical intraepithelial neoplasia). Semin Cutan Med Surg 1999; 18: 3–14. 21 Cockerell CJ. Histopathology of incipient intraepidermal squamous cell carcinoma ("actinic keratosis"). J Am Acad Dermatol 2000; 42: S11–S17. 22 Camacho Martinez F. Actinic keratosis. In: AD Katsambas, TM Lotti eds. European Handbook of Dermatological Treatments, 2nd edn. Berlin, Heidelberg, New York: Springer-Verlag: 2003: 10–15. 23 Feldman SR, Fleisher AB, Williford PM, et al. Destructive procedures are the standard of care for treatment of actinic keratoses. J Am Acad Dermatol 1999; 40: 43–47. 24 Lubritz RR, Smolewski SA. Cryosurgery cure rate of actinic keratoses. Int J Dermatol 1996; 35: 533–538. 25 Chiarello SE. Cryopeeling (extensive cryosurgery) for treatment of actinic keratoses: an update and comparison. Dermatol Surg 2000; 26: 728–732. 26 Kuflik EG. Cryosurgery updated. J Am Acad Dermatol 1994; 31: 925–934. 27 Coleman WP, Yarborough JM, Mandy SH. Dermabrasion for prophylaxis and treatment of actinic keratoses. Dermatol Surg 1996; 22: 17–21. 28 Iyer S, Friedli A, Bowes L, et al. Full face laser resurfacing: therapy and prophylaxis for actinic keratoses and non-melanoma skin cancer. Lasers Surg Med 2004; 34: 114–119. 29 Trimas SJ, Ellis DA, Metz RD. The carbon dioxide laser. An alternative for the treatment of actinically damaged skin. Dermatol Surg 1998; 24: 933–934. 30 Massey SA, Eliezri Y. A case report of laser resurfacing as a skin cancer prophylaxis. Dermatol Surg 1999; 25: 513–516. 31 Stulberg DL, Crandell B, Fawcett RS. Diagnosis and treatment of basal cell and squamous cell carcinomas. Am Fam Physician 2004; 70: 1481–1488. 32 Barta U, Grafe T, Wollina U. Radiation therapy for extensive actinic keratosis. J Eur Acad Dermatol 2000; 14: 293–295. 33 Eaglstein WH, Weinstein GD, Frost P. Fluorouracil: mechanism of action in human skin and actinic keratoses, effect on DNA synthesis in vivo. Arch Dermatol 1979; 101: 132–139. 34 Robins P, Gupta AK. The use of topical fluorouracil to treat actinic keratosis. Cutis 2002; 70: 4–7. 35 Correale CE. AK: new treatment options. Adv Dermatol 2002; 18: 339–355. 36 Pearlman DL. Weekly pulse dosing: effective and comfortable topical 5-fluorouracil treatment of multiple facial actinic keratoses. J Am Acad Dermatol 1991; 25: 665–667. 37 Stockfleth E, Meyer T, Benninghoff B, et al. A randomized, double-blind, vehicle controlled study to assess 5% imiquimod cream for the treatment of multiple AK. Arch Dermatol 2002; 138: 1498–1502. 38 Stanley MA. Mechanism of action of imiquimod. Papillomavirus Rep 1999; 10: 23–29. 39 Salasche SJ, Levine N, Morrison L. Cycle therapy of actinic keratoses of the face and scalp with 5% topical imiquimod cream: an open-label trial. J Am Acad Dermatol 2002; 47: 571–577. 40 Riendeau D, Percival MD, Brideau C, et al. Etoricoxib (MK-0663): preclinical profile and comparison with other agents that selectively inhibit cycloxygenase-2. J Pharmacol Exp Ther 2001; 296: 558–566. 41 Wolf JE Jr, Taylor JR, Tschen E, et al. Topical 3.0% diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses. Int J Dermatol 2001; 40: 709–713. 42 Rivers JK, Arlette J, Shear N, et al. Topical treatment of actinic keratoses with topical 3.0% diclofenac in 2.5% hyaluronan gel. Br J Dermatol 2002; 246: 94–100. 43 Jarvis B, Figgitt DP. Topical 3.0% diclofenac in 2.5% hyaluronan gel: a review of its use in patients with actinic keratoses. Am J Clin Dermatol 2003; 4: 203–213. 44 Witheiler DD, Lawrence N, Cox SE, et al. Long-term efficacy and safety of Jessner's solution and 35% trichloroacetic acid vs 5% fluorouracil in the treatment of widespread facial actinic keratosis. Dermatol Surg 1997; 23: 191–196. 45 Sander CA, Pfeiffer Ch, Kligman AM, et al. Chemotherapy for disseminated actinic keratoses with 5-fluorouracil and isotretinoin. J Am Acad Dermatol 1997; 36: 236–238. 46 Edwards L. The interferons. Dermatol Clin 2001; 19: 139–146. 47 Jeffes EW. Levulan: the first approved topical photosensitizer for the treatment of actinic keratosis. J Dermatol Treat 2002; 13: S19–S23. 48 Rossi R, Mavilia L, Ghersetich I, et al. Photodynamic therapy of actinic keratoses with methyl-aminolevulinate (Metvix). G Ital Dermatol Venereol 2005; 140: 381–387. 49 Rossi R, Lotti T, Cappugi P, et al. Guidelines for photodynamic therapy in dermatology: treatment protocol. G Ital Dermatol Venereol 2005; 140: 637–644. 50 Cappugi P, Campolmi P, Mavilia L, et al. Topical 5-aminolevulinic acid and photodynamic therapy in dermatology: a minireview. J Chemother 2001; 13: 494–502. 51 Diffey BL. Sun protection with clothing. Editorial comments. Br J Dermatol 2001; 144: 449–450. Citing Literature Volume46, Issue9September 2007Pages 895-904 ReferencesRelatedInformation

Referência(s)